Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Author:

Locke Frederick L.1,Miklos David B.1,Jacobson Caron A.1,Perales Miguel-Angel1,Kersten Marie-José1,Oluwole Olalekan O.1,Ghobadi Armin1,Rapoport Aaron P.1,McGuirk Joseph1,Pagel John M.1,Muñoz Javier1,Farooq Umar1,van Meerten Tom1ORCID,Reagan Patrick M.1,Sureda Anna1,Flinn Ian W.1,Vandenberghe Peter1,Song Kevin W.1,Dickinson Michael1,Minnema Monique C.1,Riedell Peter A.1,Leslie Lori A.1,Chaganti Sridhar1,Yang Yin1,Filosto Simone1,Shah Jina1,Schupp Marco1,To Christina1,Cheng Paul1,Gordon Leo I.1,Westin Jason R.1ORCID

Affiliation:

1. From the H. Lee Moffitt Cancer Center, Tampa, FL (F.L.L.); Stanford University School of Medicine, Stanford (D.B.M.), and Kite, a Gilead company, Santa Monica (Y.Y., S.F., J.S., M.S., C.T., P.C.) — both in California; Dana–Farber Cancer Institute, Boston (C.A.J.); Memorial Sloan Kettering Cancer Center, New York (M.-A.P.), and the University of Rochester School of Medicine, Rochester (P.M.R.) — both in New York; Amsterdam Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam (M.-J.K...

Funder

Kite, a Gilead company

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3